Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alnylam Pharmaceuticals Company Profile (NASDAQ:ALNY)

Consensus Ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) (?)
Ratings Breakdown: 3 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $88.00 (0.01% upside)

Analysts' Ratings History for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/18/2014Leerink SwannInitiated CoverageOutperform$103.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2014ZacksReiterated RatingNeutral -> Neutral$69.00ViewTweet This Rating  Share This Rating on StockTwits
7/21/2014ZacksReiterated RatingNeutral -> Neutral$57.00ViewTweet This Rating  Share This Rating on StockTwits
2/14/2014Needham & Company LLCBoost Price TargetBuy$65.00 -> $84.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014JMP SecuritiesBoost Price Target$68.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
1/17/2014Deutsche BankBoost Price TargetBuy$80.00 -> $108.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2014Morgan StanleyDowngradeOverweight -> Equal Weight$72.00 -> $54.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2014S&P Equity ResearchDowngradeNeutralViewTweet This Rating  Share This Rating on StockTwits
1/13/2014JMP SecuritiesReiterated RatingMarket PerformViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Leerink SwannBoost Price TargetOutperform$80.00 -> $82.00ViewTweet This Rating  Share This Rating on StockTwits
9/24/2013Deutsche BankBoost Price TargetBuy$60.00 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Needham & Company LLCUpgradePositive$55.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Leerink SwannBoost Price TargetOutperform$57.00 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Needham & Company LLCBoost Price TargetBuy$40.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2013JMP SecuritiesSet Price Target$44.00 -> $68.00ViewTweet This Rating  Share This Rating on StockTwits
7/12/2013JPMorgan Chase & Co.Boost Price TargetOverweight$28.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
7/12/2013Piper JaffraySet Price TargetOverweight$42.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
7/12/2013Deutsche BankBoost Price TargetBuy$40.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2013Needham & Company LLCReiterated RatingBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2013JMP SecuritiesBoost Price TargetOutperform$33.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2013Leerink SwannBoost Price Target$45.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2013Needham & Company LLCBoost Price TargetBuy$28.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
7/1/2013Piper JaffraySet Price Target$36.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Morgan StanleyInitiated CoverageOverweight$35.00ViewTweet This Rating  Share This Rating on StockTwits
5/24/2013Deutsche BankInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
2/12/2013MLV & Co Boost Price Target$20.00 -> $27.50ViewTweet This Rating  Share This Rating on StockTwits
2/11/2013MLV & Co DowngradeBuy -> Hold$20.00 -> $27.50ViewTweet This Rating  Share This Rating on StockTwits
2/8/2013JMP SecuritiesInitiated CoverageOutperform$33.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2013Needham & Company LLCBoost Price Target$28.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Piper JaffrayReiterated RatingOverweight$25.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
12/12/2012Piper JaffrayUpgradeNeutral -> Overweight$19.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/20/2012 forward)
Discuss Alnylam Pharmaceuticals